Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer

Journal of Clinical Microbiology

Volumn 47, Issue 2, 2009, Pages 287-293

  Cheung, Jo L K ^a   Cheung, Tak Hong ^a   Ng, Candy W Y ^a   Yu, Mei Y ^a   Wong, Martin C S ^a   Siu, Shing Shun N ^a   Yim, So Fan ^a   Chan, Paul K S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PHYSIOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18;

ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN;

ADULT; FEMALE; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 60849119264     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01531-08     Document Type: Article

References (35)

1. Andersson, S., H. Safari, M. Mints, I. Lewensohn-Fuchs, U. Gyllensten, and B. Johansson. 2005. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer. 92:2195-2200.
2. Berumen, J., L. Casas, E. Segura, J. L. Amezcua, and A. Garcia-Carranca. 1994. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int. J. Cancer 56:640-645.
3. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
4. Carcopino, X., M. Henry, D. Benmoura, A. S. Fallabregues, H. Richet, L. Boubli, and C. Tamalet. 2006. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J. Med. Virol. 78:1131-1140.
5. Chan, P. K., J. L. Cheung, T. H. Cheung, K. W. Lo, S. F. Yim, S. S. Siu, and J. W. Tang. 2007. Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia. J. Infect. Dis. 196:868-875.
6. Cheung, J. L., T. H. Cheung, J. W. Tang, and P. K. Chan. 2008. Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer. J. Clin. Microbiol. 46:1356-1362.
7. Cheung, J. L., K. W. Lo, T. H. Cheung, J. W. Tang, and P. K. Chan. 2006. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J. Infect. Dis. 194:1706-1712.
8. Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer. 88:63-73.
9. Corden, S. A., L. J. Sant-Cassia, A. J. Easton, and A. G. Morris. 1999. The integration of HPV-18 DNA in cervical carcinoma. Mol. Pathol. 52:275-282.
10. Cullen, A. P., R. Reid, M. Campion, and A. T. Lörincz. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
11. Cuzick, J., G. Terry, L. Ho, T. Hollingworth, and M. Anderson. 1994. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br. J. Cancer 69:167-171.
12. Dalstein, V., D. Riethmuller, J. L. Pretet, K. Le Bail Carval, J. L. Sautiere, J. P. Carbillet, B. Kantelip, J. P. Schaal, and C. Mougin. 2003. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer 106:396-403.
13. Gravitt, P. E., R. D. Burk, A. Lorincz, R. Herrero, A. Hildesheim, M. E. Sherman, M. C. Bratti, A. C. Rodriguez, K. J. Helzlsouer, and M. Schiffman. 2003. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol. Biomarkers Prev. 12:477-484.
14. Häfner, N., C. Driesch, M. Gajda, L. Jansen, R. Kirchmayr, I. B. Runnebaum, and M. Dürst. 2008. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27:1610-1617.
15. Ho, C. M., T. Y. Chien, S. H. Huang, B. H. Lee, and S. F. Chang. 2006. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol. Oncol. 102:54-60.
16. Hong Kong Cancer Registry, Hospital Authority. 2005. Facts on cervical cancer. Hong Kong Cancer Registry, Hospital Authority, Hong Kong. http://www3.ha.org.hk/cancereg/eng/cx.pdf.
17. Huang, L. W., S. L. Chao, and B. H. Lee. 2008. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J. Clin. Pathol. 61:627-631.
18. Huang, Y., M. N. Huang, N. Li, X. G. Li, N. Li, and L. Y. Wu. 16 November 2007, posting date. Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. Int. J. Gynecol. Cancer 18:755-760. [Epub ahead of print.]
19. Hudelist, G., M. Manavi, K. I. Pischinger, T. Watkins-Riedel, C. F. Singer, E. Kubista, and K. F. Czerwenka. 2004. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92:873-880.
20. Josefsson, A. M., P. K. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, P. K. Andersen, M. Melbye, H. O. Adami, and U. B. Gyllensten. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355:2189-2193.
21. Kalantari, M., F. Karlsen, G. Kristensen, R. Holm, B. Hagmar, and B. Johansson. 1998. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int. J. Gynecol. Pathol. 17:146-153.
22. Manavi, M., G. Hudelist, A. Fink-Retter, D. Gschwantler-Kaulich, K. Pischinger, and K. Czerwenka. 2008. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. Int. J. Gynecol. Cancer 18:285-294.
23. Mansell, M. E., L. Ho, G. Terry, A. Singer, and J. Cuzick. 1994. Semi-quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality. Br. J. Obstet. Gynaecol. 101:807-809.
24. Moberg, M., I. Gustavsson, E. Wilander, and U. Gyllensten. 2005. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br. J. Cancer 92:891-894.
25. Muñoz, N., F. X. Bosch, S. de Sanjosé, R. Herrero, X. Castellsagué, K. V. Shah, P. J. Snijders, C. J. Meijer, and the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
26. Onan, M. A., C. Taskiran, G. Bozdayi, A. Biri, O. Erdem, A. Acar, G. Gunaydin, S. Rota, O. Ataoglu, and H. Guner. 2005. Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. Eur. J. Gynaecol. Oncol. 26:632-635.
27. Pirami, L., V. Giache, and A. Becciolini. 1997. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J. Clin. Pathol. 50:600-604.
28. Schlecht, N. F., A. Trevisan, E. Duarte-Franco, T. E. Rohan, A. Ferenczy, L. L. Villa, and E. L. Franco. 2003. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 103:519-524.
29. Snijders, P. J., C. J. Hogewoning, A. T. Hesselink, J. Berkhof, F. J. Voorhorst, M. C. Bleeker, and C. J. Meijer. 2006. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int. J. Cancer 119:1102-1107.
30. Swan, D. C., R. A. Tucker, G. Tortolero-Luna, M. F. Mitchell, L. Wideroff, E. R. Unger, R. A. Nisenbaum, W. C. Reeves, and J. P. Icenogle. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1030-1034.
31. van Duin, M., P. J. Snijders, H. F. Schrijnemakers, F. J. Voorhorst, L. Rozendaal, M. A. Nobbenhuis, A. J. van den Brule, R. H. Verheijen, T. J. Helmerhorst, and C. J. Meijer. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer 98:590-595.
32. Vinokurova, S., N. Wentzensen, I. Kraus, R. Klaes, C. Driesch, P. Melsheimer, F. Kisseljov, M. Dürst, A. Schneider, and M. von Knebel Doeberitz. 2008. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 68:307-313.
33. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Muñoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
34. Wensveen, C. W., M. J. Kagie, N. J. Nagelkerke, R. W. Veldhuizen, and J. B. Trimbos. 2005. Can. viral load, semi-quantitatively evaluated, of human papillomavirus predict cytological or histological outcome in women with atypical squamous or glandular cells of undetermined significance cytology? Eur. J. Gynaecol. Oncol. 26:393-397.
35. Woodman, C. B., S. I. Collins, and L. S. Young. 2007. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer. 7:11-22.